Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial
- 1 February 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9663), 567-574
- https://doi.org/10.1016/s0140-6736(09)60205-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effectiveness of Warfarin among Patients with CancerJournal of General Internal Medicine, 2007
- Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With CancerJournal of Clinical Oncology, 2006
- Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialAnnals of Oncology, 2005
- Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With CancerJournal of Clinical Oncology, 2005
- Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer PatientsJournal of Clinical Oncology, 2005
- Catheter-Associated Thrombosis: Thromboprophylaxis or Not?Journal of Clinical Oncology, 2005
- Thrombotic Complications of Central Venous Catheters in Cancer PatientsThe Oncologist, 2004
- Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer PatientsJournal of Clinical Oncology, 2003
- Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosisInternal Medicine Journal, 2002
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958